SCHEMBL4904938

SCHEMBL4904938

C=C(C)C(=O)OCC1CCC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
TSHR P16473 3/20 0.44
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.41
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
ADORA2B P29275 4/20 0.35
PARP15 Q460N3 1/20 0.34
PARP10 Q53GL7 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
EPHX1 P07099 1/20 0.33
JMJD6 Q6NYC1 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15928283 0.96 ALDH1A1 (0.56) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL6081993 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL105131 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL1832544 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL5936685 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL23493948 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL8408212 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL15608263 0.94 ALDH1A1 (0.55) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL2783062 0.92 ALDH1A1 (0.53) ALDH1A1TSHRLMNATHRBSLC1A3
SCHEMBL496421 0.92 ALDH1A1 (0.60) ALDH1A1TSHRLMNATHRBSLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080003288-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2008-01-03 US disclosed
US-7204997-B2 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2007-04-17 US disclosed
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
US-20030152623-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2003-08-14 US disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
US-6491903-B1 NARROW MOLECULAR WEIGHT DISTRIBUTION SHELL-CORE POLYMERS HAVING HYDROPHILIC, CROSSLINKED PERMEABLE SHELLS AND HYDROPHOBIC CORES, USED FOR REDUCING BLOOD CHOLESTEROL AND BILE ACID UPTAKE IN INTERSTINES; DRUG DELIVERY WASHINGTON UNIVERSITY 2002-12-10 US disclosed
US-6383500-B1 Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications WASHINGTON UNIVERSITY 2002-05-07 US disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed